http://www.iacfsme.org/LinkClick.aspx?fileticket=EFIrm+uCnkM=&tabid=142
Page 53
Compasionate Use Treatment of CFS with GcMAF.
Only 18 patients
333 % had significant to clinically resolved response...
278 % failed to respond or get worse
389 % mild to morate improvement...
The non responders can be predicted because the VDR genomics.
Page 53
Compasionate Use Treatment of CFS with GcMAF.
Only 18 patients
333 % had significant to clinically resolved response...
278 % failed to respond or get worse
389 % mild to morate improvement...
The non responders can be predicted because the VDR genomics.